Michelle Smolenaars Hunter
Michelle Smolenaars Hunter is a spokesperson for GSK, the pharmaceutical company developing gepotidacin, a promising new antibiotic for treating gonorrhea. She has announced plans for a U.S. regulatory submission for gepotidacin's use against uncomplicated gonorrhea, reflecting the company's commitment to addressing the urgent need for effective treatments amid rising antibiotic resistance.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Michelle Smolenaars Hunter is a spokesperson for GSK who stated that the company plans to file a U.S. regulatory submission for gepotidacin.
7